Epidemiology of transthyretin (ATTR) amyloidosis: a systematic literature review

Abstract Introduction Significant advances in the treatment of transthyretin (ATTR) amyloidosis has led to an evolving understanding of the epidemiology of this condition. This systematic literature review (SLR) aims to synthesize current evidence on epidemiology and mortality outcomes in ATTR amylo...

Full description

Bibliographic Details
Published in:	Orphanet Journal of Rare Diseases
Main Authors:	Diego Delgado, Firas Dabbous, Nitin Shivappa, Faizan Mazhar, Eric Wittbrodt, Divya Shridharmurthy, Krister Järbrink
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Online Access:	https://doi.org/10.1186/s13023-025-03547-0

Similar Items

Transthyretin Kinetic Stabilizers for ATTR Amyloidosis
by: Jeffery W. Kelly
Published: (2025-07-01)

Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis Care
by: Julian D. Gillmore, et al.
Published: (2025-03-01)

Correction: Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis Care
by: Julian D. Gillmore, et al.
Published: (2025-05-01)

World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
by: Dulce Brito (Chair), et al.
Published: (2023-10-01)

Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis)
by: Sergey N. Tereshchenko, et al.
Published: (2022-05-01)

Inotersen to Treat Polyneuropathy Associated with Hereditary Transthyretin (hATTR) Amyloidosis
by: Christopher Robinson, et al.
Published: (2023-01-01)

Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review
by: Emre Aldinc, et al.
Published: (2023-09-01)

Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis
by: Maximilian Steinebrei, et al.
Published: (2023-11-01)

Transthyretin Kinetic Stabilizers for ATTR Amyloidosis: A Narrative Review of Mechanisms and Therapeutic Benefits
by: Evan T. Powers, et al.
Published: (2025-07-01)

Reliability and validity of the Transthyretin Amyloidosis – Quality of Life (ATTR-QOL) Questionnaire impact scales
by: Andrew Lovley, et al.
Published: (2025-04-01)

Efficacy and safety of diflunisal therapy in patients with transthyretin cardiac amyloidosis (ATTR-CA): a systematic review and meta-analysis
by: Wilbert Huang, et al.
Published: (2025-03-01)

Monitoring patients and asymptomatic carriers with hereditary transthyretin amyloidosis: regional protocol of Emilia-Romagna ATTR working group
by: Pietro Guaraldi, et al.
Published: (2025-08-01)

ATTR Variant Amyloidosis in Patients with Dysphagia
by: Christina Hui Lee Ng, et al.
Published: (2023-06-01)

Hereditary Transthyretin Amyloidosis (hATTR) with Polyneuropathy Clusters Are Located in Ancient Mining Districts: A Possible Geochemical Origin of the Disease
by: Per M. Roos, et al.
Published: (2024-06-01)

Unusual presentation of transthyretin (ATTR) cardiac amyloidosis: A case report of pruritus as a possible initial symptom and challenging diagnosis
by: Massood Baghaee, et al.
Published: (2023-09-01)

Benefits of Patisiran on Functional Capacity in ATTR Cardiac Amyloidosis
by: John L. Berk, MD, et al.
Published: (2025-08-01)

The Transthyretin Amyloidosis – Quality of Life (ATTR-QOL) Questionnaire: Development of a Conceptual Model and Disease-Specific Patient-Reported Outcome Measure
by: O'Connor M, et al.
Published: (2023-07-01)

A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis
by: Teresa Coelho, et al.
Published: (2020-07-01)

Comparative Study on Cardiac Findings in Patients with Transthyretin Amyloidosis Before and After Treatment with a Transthyretin Silencer
by: Priya Arivalagan, et al.
Published: (2025-09-01)

Vutrisiran in Transthyretin Amyloidosis
by: Ronald M. Witteles, MD, et al.
Published: (2025-09-01)

Hereditary transthyretin amyloidosis
by: T. A. Adyan, et al.
Published: (2020-01-01)

Management of transthyretin amyloidosis
by: Adalgisa Condoluci, et al.
Published: (2021-10-01)

Early identification of cardiac ATTR amyloidosis: a clinical case
by: A. A. Vedernikov, et al.
Published: (2024-07-01)

Systemic ATTR-amyloidosis, a Rare Form of Internal Organ Damage
by: V. V. Rameev, et al.
Published: (2019-07-01)

Increasing clinicians’ suspicion of ATTR amyloidosis using a retrospective algorithm
by: Jessica Ammon, et al.
Published: (2024-11-01)

Dynamic changes of intracellular signals in ATTR Tyr114Cys amyloidosis
by: Kenta Ouchi, et al.
Published: (2025-06-01)

Difficulties in differential diagnosis of the AL- and ATTR-cardiac amyloidosis. Case report
by: Filipp I. Orlov, et al.
Published: (2023-11-01)

Long Term Prognostic Significance of CMR and Echocardiographic Parameters in ATTR Amyloidosis
by: Joseph Justin Regalado, MD, et al.
Published: (2024-01-01)

Advances in the treatment of transthyretin amyloidosis
by: Intissar Anan
Published: (2025-07-01)

Erratum to: Management of transthyretin amyloidosis
by: Swiss Medical Weekly
Published: (2021-11-01)

ATTR Epidemiology, Genetics, and Prognostic Factors
by: Chukwuemeka A. Obi, et al.
Published: (2022-03-01)

Co‐Existing ATTR Amyloidosis and Coronary Artery Disease: A Risky Combination
by: Arnaud Planchat, et al.
Published: (2025-10-01)

Structural polymorphism of amyloid fibrils in ATTR amyloidosis revealed by cryo-electron microscopy
by: Binh An Nguyen, et al.
Published: (2024-01-01)

Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy
by: Luca Gentile, et al.
Published: (2021-04-01)

Microvascular Obstruction in AL and ATTR Cardiac Amyloidosis: Prevalence, Characterisation and Prognostic Implication
by: Lucrezia Netti, MD, et al.
Published: (2024-01-01)

Deep Learning to Classify AL versus ATTR Cardiac Amyloidosis MR Images
by: Philippe Germain, et al.
Published: (2023-01-01)

Patient with ATTR cardiac amyloidosis presenting with heart failure with reduced ejection fraction
by: Jay Gohri, et al.
Published: (2024-01-01)

Clinical case of generalized amyloidosis (ATTR-amyloidosis) with a progressive course of chronic heart failure. Case report
by: Daria P. Golubovskaya, et al.
Published: (2024-07-01)

Clinical case of hereditary transthyretin amyloidosis
by: N. Spasova, et al.
Published: (2024-12-01)

Kidney, the Cinderella Story of Transthyretin Amyloidosis
by: Nelson Leung
Published: (2025-06-01)